Over 25 years of building the life science venture capital activities at Wellington Partners, I have been deeply involved as an investor and/or board member in a number of significant success stories that we helped to create, including Actelion, immatics, Oxford Immunotec, Quanta Dialysis Technologies, Definiens, Amboss, eGenesis, Adrenomed and many others. I continue to be impressed by new ideas being introduced to us on an almost daily basis by the some of the most talented founders and entrepreneurs in Europe, and I am very excited to participate in the development of novel products that have the potential to become game changers in many areas of high unmet medical need.
Managing Partner at Wellington Partners
MSc/MBA, Economics